Literature DB >> 23182330

Cyclosporine in veterinary dermatology.

Brian S Palmeiro1.   

Abstract

Cyclosporine is an immunomodulatory medication that is efficacious and approved for atopic dermatitis in dogs and allergic dermatitis in cats; it has also been used to successfully manage a variety of immune-mediated dermatoses in dogs and cats. This article reviews the use of cyclosporine in veterinary dermatology including its mechanism of action, pharmacokinetics, drug interactions, side effects, and relevant clinical updates. Dermatologic indications including atopic/allergic dermatitis, perianal fistulas, sebaceous adenitis, and other immune-mediated skin diseases are discussed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23182330     DOI： 10.1016/j.cvsm.2012.09.007

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN： 0195-5616            Impact factor:   2.093


  10 in total

Review 1.  Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

Authors:  Tim Nuttall; Douglas Reece; Elizabeth Roberts
Journal:  Vet Rec       Date:  2014-03       Impact factor: 2.695

2.  Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.

Authors:  Ramiro Dip; James Carmichael; Ingrid Letellier; Guenther Strehlau; Elizabeth Roberts; Emmanuel Bensignor; Wayne Rosenkrantz
Journal:  BMC Vet Res       Date:  2013-09-03       Impact factor: 2.741

3.  Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies.

Authors:  Christelle Navarro; Nolwenn Crastes; Elodie Benizeau; David McGahie
Journal:  Ir Vet J       Date:  2015-02-12       Impact factor: 2.146

4.  Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs.

Authors:  Tarini Ullal; Yoko Ambrosini; Sangeeta Rao; Cynthia R L Webster; David Twedt
Journal:  J Vet Intern Med       Date:  2019-08-08       Impact factor: 3.333

5.  A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus.

Authors:  Eric Chong; Michaela Austel; Frane Banovic
Journal:  Vet Sci       Date:  2022-03-23

6.  Pharmacokinetics and bioequivalence of two cyclosporine oral solution formulations in cats.

Authors:  Yuxin Yang; Jingyuan Kong; Yu Liu; Qinyao Wu; Yuying Cao; Jicheng Qiu; Lu Zhang; Xiaohui Gong; Fuhua Zhao; Xingyuan Cao; Jianzhong Wang
Journal:  Front Vet Sci       Date:  2022-08-10

7.  Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats.

Authors:  E S Roberts; K A Vanlare; G Strehlau; M Peyrou; L M Roycroft; S King
Journal:  J Vet Pharmacol Ther       Date:  2013-10-18       Impact factor: 1.786

8.  Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs.

Authors:  C Navarro; L Séguy; M Vila; P Birckel
Journal:  BMC Vet Res       Date:  2016-03-12       Impact factor: 2.741

Review 9.  A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics.

Authors:  Victoria Mutua; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

10.  Clinical and histological recovery of non-thymoma-associated exfoliative dermatitis in a cat treated with ciclosporin A.

Authors:  Daniel Combarros; Jean-Paul Moulin; Sophie Correge; Maxence Delverdier; Marie-Christine Cadiergues
Journal:  JFMS Open Rep       Date:  2020-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.